BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 53 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $299,000 | -52.3% | 1,210,537 | 0.0% | 0.02% | -51.4% |
| Q2 2022 | $627,000 | -74.7% | 1,210,537 | 0.0% | 0.04% | -68.5% |
| Q1 2022 | $2,482,000 | -50.8% | 1,210,537 | 0.0% | 0.11% | -40.3% |
| Q4 2021 | $5,048,000 | +3874.8% | 1,210,537 | +8786.6% | 0.19% | +3620.0% |
| Q3 2021 | $127,000 | -47.1% | 13,622 | +2.4% | 0.01% | -44.4% |
| Q2 2021 | $240,000 | – | 13,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|